Tutorials › Competing Risks and Multi-State Models › Common Mistakes in Competing-Risk Causal Analysis

Causal Contrasts With Competing Events · Tutorial 209 of 699

Common Mistakes in Competing-Risk Causal Analysis

Learn how to recognize and correct common causal-interpretation errors when competing events affect who can experience the event of interest.

Advanced 12 min read

What You'll Learn

  • Distinguish observed treatment-policy cumulative incidence from risk under a hypothetical intervention eliminating competing events.
  • Identify the assumptions needed before censoring competing events can represent a hypothetical intervention.
  • Explain why treatment-specific survivor groups need not be comparable, even in a randomized study.
  • Interpret cause-specific hazard ratios without treating them as absolute causal effects.
  • Check causal claims against estimands, risk sets, competing-event patterns, and absolute risks.

Why Causal Competing-Risk Analyses Are Easy to Misread

A competing event changes more than the event label: once it occurs, the event of interest can no longer occur first. That feature creates several tempting but incorrect shortcuts. Censoring competing events may silently change the question; comparing people who remain event-free may compare selected groups; and a hazard ratio may be mistaken for an absolute change in risk. Each error can produce a number that is mathematically computable but does not answer the causal question being asked.

The starting point is to specify the outcome and the intervention. Let \(A\in\{0,1\}\) denote treatment, \(T^a\) the time to the first event under treatment level \(a\), and \(J^a\) its cause. Cause \(k\) is the event of interest; other causes can prevent it. The treatment-policy cumulative incidence is the probability that cause \(k\) has occurred by time \(t\) under treatment \(a\), with competing events allowed to occur naturally.

Definition: The treatment-policy cumulative incidence for cause \(k\) under treatment \(a\) is \(F_k^a(t)=P(T^a\leq t,\ J^a=k)\). It is an absolute risk by time \(t\) under that treatment policy. The corresponding causal risk difference is \(F_k^1(t)-F_k^0(t)\), and the risk ratio is \(F_k^1(t)/F_k^0(t)\), when the denominator is positive. These contrasts compare specified treatment regimes; they do not automatically identify the effect of a different intervention on competing events.

For a continuous-time model with absolutely continuous cause-specific hazards \(\lambda_j^a(u)\), the event-free probability is \(S^a(u)=\exp\{-\int_0^u\sum_j\lambda_j^a(v)\,dv\}\). The cumulative incidence is obtained by accumulating the cause-\(k\) event hazard among people who have not yet had any event:

$$ F_k^a(t)=\int_0^t S^a(u)\lambda_k^a(u)\,du. $$

This formula assumes absolutely continuous cause-specific hazards, so event probability accumulates through a hazard density over time. If event-time jumps are allowed, the corresponding measure-based expression is \(F_k^a(t)=\int_0^t S^a(u-)\,d\Lambda_k^a(u)\), where \(\Lambda_k^a\) is the cause-specific cumulative hazard measure and \(S^a(u-)\) is the probability of remaining event-free just before \(u\). The left limit matters at jumps: people experiencing an event at \(u\) must be in the risk set immediately before that event.

Mistake 1: Censoring Competing Events Without Defining the Intervention

A common analysis treats each competing event as if it were ordinary right-censoring and then uses a Kaplan–Meier-type calculation for the event of interest. That calculation does not generally estimate the treatment-policy cumulative incidence. Instead, it removes competing events from the calculation of event-free survival, producing a net-risk quantity associated with a hypothetical world in which competing causes have been eliminated while the cause-specific hazard for the event of interest is held fixed. In the continuous model, this quantity is \(1-\exp\{-\int_0^t\lambda_k^a(u)\,du\}\).

That hypothetical quantity is not automatically the risk under a real intervention. Such an interpretation needs a well-defined intervention that eliminates or prevents the competing event, together with assumptions that support the intervention’s effect on the event of interest. For example, it may be implausible that preventing a competing event leaves the target-event process unchanged. A hypothetical calculation also needs appropriate control of confounding and censoring, positivity for the intervention being considered, and consistency between the intervention and the observed data. Merely relabeling a competing event as “censored” establishes none of these conditions.

Worked Example: Net Risk Is Not the Observed-World Risk

Consider a hypothetical treatment group with constant cause-specific hazards per year: \(\lambda_k=0.10\) for the event of interest and \(\lambda_c=0.10\) for a competing event. Assume the continuous-hazard model applies through five years. The event-free probability at time \(u\) is \(S(u)=\exp(-0.20u)\).

The treatment-policy cumulative incidence at five years is

$$ F_k(5)=\int_0^5 e^{-0.20u}(0.10)\,du =\frac{0.10}{0.20}(1-e^{-1}) =0.3161. $$

Thus, under the specified treatment policy, the probability of experiencing the event of interest first by five years is about 31.6%. If competing events are instead removed from the survival calculation, the net risk is

$$ 1-e^{-(0.10)(5)}=1-e^{-0.5}=0.3935. $$

That is about 39.3%, not the treatment-policy risk. The difference arises because the competing-event hazard removes some people from the possibility of later experiencing the event of interest. The larger net-risk number may be relevant to a defensible hypothetical intervention that eliminates the competing event and preserves the target hazard, but censoring alone does not establish that interpretation.

A practical diagnostic is to ask what the reported estimand says happens to competing events. If the scientific question concerns risk under usual treatment assignment, competing events remain part of the outcome process and the target is a cumulative incidence. If the question is explicitly hypothetical, state the intervention and explain why its effect on the target event can be identified. A mismatch between the question and the analysis is a warning even when the calculation itself is correct.

Mistake 2: Treating Survivors as Though They Were Comparable

A cause-specific hazard at time \(t\) is the instantaneous rate of the event of interest among people who are still event-free just before \(t\). Under treatment \(a\), that risk set consists of people satisfying \(T^a\geq t\). If treatment changes the frequency of competing events, the people who remain event-free can differ between treatment regimes. A comparison of their hazards therefore compares treatment-specific, selected risk sets, not necessarily the same underlying people.

Randomization makes treatment groups comparable at baseline, but it does not make the groups still event-free at a later time comparable. Remaining event-free is affected by treatment and by prognosis. Conditioning on it can induce an association between treatment and prognostic characteristics, even when they were independent at baseline. A hazard ratio can still be a useful description of the ratio of the two regime-specific cause-specific hazards; it is not, without further assumptions and a carefully stated target, an absolute causal effect for a common population.

Worked Example: Survivor Selection Changes the Comparison

Suppose a hypothetical randomized study begins with 100 people in each arm: 50 with a high-risk profile and 50 with a low-risk profile. During an initial period, treatment has no effect on the target event within either profile, but it changes the competing-event probability. In the control arm, 10% of each profile experience the competing event. In the treatment arm, 50% of the high-risk profile and 10% of the low-risk profile experience it. Assume no target events occur during this initial period.

Among control survivors, 45 high-risk and 45 low-risk people remain, for 90 total. Among treatment survivors, 25 high-risk and 45 low-risk people remain, for 70 total. In a subsequent period, suppose the target-event risk is 0.40 for the high-risk profile and 0.10 for the low-risk profile, with those risks the same under either treatment.

The target-event risk among control survivors is

$$ \frac{45(0.40)+45(0.10)}{90} =\frac{18+4.5}{90} =0.250. $$

Among treatment survivors it is

$$ \frac{25(0.40)+45(0.10)}{70} =\frac{10+4.5}{70} =0.2071. $$

The 4.29-percentage-point difference between these survivor-group risks does not show that treatment reduced the target-event risk within either profile: the stipulated profile-specific risks were unchanged. Treatment altered who survived the competing event, leaving a smaller proportion of high-risk people in its survivor group. This is a selection/composition difference, not evidence of a within-profile treatment effect. The example concerns a conditional later-period risk; it should not be confused with the total treatment-policy cumulative incidence from baseline.

When a question concerns an effect among people who would survive under either treatment, it requires a principal-stratum estimand involving jointly defined potential survival outcomes. Membership in that stratum is not observed for any individual, so it is not identified by simply restricting each arm to its observed survivors. Other estimands, such as treatment-policy risks from baseline, avoid that particular survivor restriction and should be reported when they match the scientific question.

Mistake 3: Reading a Hazard Ratio as an Absolute Effect

A hazard ratio is a relative comparison of instantaneous rates among people still event-free at each time. It is not a risk difference, a risk ratio, or a fixed percentage change in the probability of experiencing the event by a specified time. Even if proportional cause-specific hazards hold, absolute risks depend on the baseline hazards, follow-up time, and hazards of all competing causes.

Worked Example: The Same Hazard Ratio, Different Risk Differences

Use constant hazards per year and five years of follow-up. In a first hypothetical setting, the control hazards are \(\lambda_k^0=0.10\) and \(\lambda_c^0=0.10\), while treatment has \(\lambda_k^1=0.05\) and \(\lambda_c^1=0.10\). The cause-specific hazard ratio for the target event is \(0.05/0.10=0.50\). The control cumulative incidence is

$$ F_k^0(5)=\frac{0.10}{0.20}(1-e^{-0.20(5)})=0.3161, $$

and the treatment cumulative incidence is

$$ F_k^1(5)=\frac{0.05}{0.15}(1-e^{-0.15(5)})=0.1759. $$

The risk difference is \(0.1759-0.3161=-0.1402\), or about 14.0 percentage points lower under treatment at five years.

Now consider a second hypothetical setting with control hazards \(\lambda_k^0=0.02\), \(\lambda_c^0=0.02\), and treatment hazards \(\lambda_k^1=0.01\), \(\lambda_c^1=0.02\). The target-event hazard ratio is again \(0.50\). Yet

$$ F_k^0(5)=\frac{0.02}{0.04}(1-e^{-0.04(5)})=0.09063, \qquad F_k^1(5)=\frac{0.01}{0.03}(1-e^{-0.03(5)})=0.04643. $$

Here the risk difference is \(0.04643-0.09063=-0.04420\), or about 4.42 percentage points lower. The same cause-specific hazard ratio corresponds to different absolute risk differences because the underlying event rates differ. A hazard ratio alone therefore cannot supply an absolute causal effect or a number needed to treat.

Checks That Prevent These Errors

1
Name the estimand.
State the event, time horizon, treatment regimes, and whether competing events occur naturally or are hypothetically prevented.
2
Match the calculation to the estimand.
For treatment-policy event risk, use a cumulative incidence. A net-risk calculation needs a specified hypothetical intervention and supporting identification assumptions.
3
Inspect the risk sets and competing-event patterns.
Ask whether treatment changes who remains event-free, and whether the cause-specific hazard contrast is being mistaken for a contrast in absolute risks.
4
Report absolute effects at a stated time.
When the goal is clinical impact, give treatment-specific cumulative incidences and an absolute contrast with units such as percentage points by five years, alongside any relative hazard measure.

These checks do not replace identification analysis. For observational data, causal interpretations require assumptions such as consistency, conditional exchangeability given measured covariates, and positivity for the treatment regimes being compared. Censoring also requires suitable assumptions or methods. The earlier material on causal contrasts, hypothetical competing-event elimination, and positivity provides tools for defining and estimating such quantities; the essential safeguard here is not to claim an estimand that the procedure and assumptions do not support.

Common errorWhy it failsCorrection
Censor the competing event and call the result the observed risk.The calculation removes a cause that prevents the target event and generally changes the estimand.Use cumulative incidence for treatment-policy risk; state and justify a hypothetical intervention for net risk.
Compare only the people still event-free in each arm.The treatment-specific survivors can differ in prognosis because survival is post-treatment selection.State the survivor-conditioned target explicitly or report a baseline-defined treatment-policy contrast.
Translate a cause-specific hazard ratio directly into a risk reduction.A relative instantaneous rate does not determine absolute risk; competing hazards and time also matter.Report cumulative incidences and an absolute contrast at a specified follow-up time.

A final pitfall is to assume that a statistically precise estimate must answer the intended causal question. Precision concerns sampling uncertainty under an analysis; it cannot repair a mismatch between the estimand and the calculation, selection into a risk set, or unsupported assumptions about eliminating competing events. Interpret every estimate first by asking: what population, intervention, event process, and time horizon does this number describe?

Check Your Understanding

Answer each question, then compare your reasoning with the solutions below.

  1. A researcher censors competing deaths and reports a five-year target-event risk as the observed risk under treatment. What is the central problem, and what should be clarified?
  2. In a randomized trial, treatment changes the competing-event rate. Why might the cause-specific hazards among event-free participants differ in composition over time?
  3. A target-event cause-specific hazard ratio is 0.70. Can this alone establish a 30% reduction in five-year cumulative incidence? Explain.
  4. Under absolutely continuous hazards, state the formula for the cause-\(k\) cumulative incidence and identify the role of each factor.

Solutions. (1) Censoring competing deaths generally targets a net-risk quantity rather than the observed-world cumulative incidence. Clarify whether the estimand is treatment-policy risk or risk under a specified hypothetical intervention eliminating competing deaths, and justify the latter’s assumptions if intended. (2) Treatment and prognosis can both affect remaining event-free; conditioning on that post-treatment status changes the mix of prognostic types in each arm’s risk set. Baseline randomization does not prevent this selection. (3) No. A hazard ratio is a relative instantaneous-rate contrast, not an absolute risk contrast. Five-year cumulative incidence also depends on baseline and competing-event hazards and follow-up; calculate both regime-specific risks to obtain their difference. (4) \(F_k^a(t)=\int_0^t S^a(u)\lambda_k^a(u)\,du\): \(\lambda_k^a(u)\,du\) contributes target-event probability over a short interval among those at risk, and \(S^a(u)\) weights that contribution by the probability of having experienced no event before \(u\).

Clinical Biostats